CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$55.43 -0.01 (-0.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Price to Earnings (2019 - 2022)

Updated

CRISPR Therapeutics AG's Price to Earnings was 15.59 in Q1 2022, up 0.9% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Price to Earnings (2019 - 2022) Analysis & Trends

For FY2021, Price to Earnings at CRISPR Therapeutics AG came in at 15.45.

  • In earlier years, Price to Earnings was 55.37 in FY2019.
  • Quarterly Price to Earnings has moved between 15.45 (Q4 2021) and 234.80 (Q2 2020) over five years.
  • Per Business Quant data, CRSP's Price to Earnings in the three quarters before Q1 2022 was 15.45 (Q4 2021), 20.78 (Q3 2021) and 27.58 (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CRISPR Therapeutics AG 5.36 Bn 5.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 15.59
Dec 31, 2021 15.45
Sep 30, 2021 20.78
Jun 30, 2021 27.58
Jun 30, 2020 234.80
Mar 31, 2020 56.71
Dec 31, 2019 55.37
API Access

CRISPR Therapeutics AG Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CRSP&period=max&api_key=YOUR_API_KEY